Pulse Biosciences (PLSE)
(Delayed Data from NSDQ)
$18.91 USD
+1.77 (10.33%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $18.90 -0.01 (-0.05%) 4:18 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.91 USD
+1.77 (10.33%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $18.90 -0.01 (-0.05%) 4:18 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Pulse Biosciences, Inc (PLSE) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Pulse Biosciences, Inc (PLSE) delivered earnings and revenue surprises of 0% and 52.17%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Pulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Pulse Biosciences, Inc (PLSE) delivered earnings and revenue surprises of 5.88% and 36.57%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Pulse Biosciences, Inc (PLSE) delivered earnings and revenue surprises of 22% and 6.22%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Pulse Biosciences, Inc (PLSE)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Moving Average Crossover Alert: Pulse Biosciences (PLSE)
by Zacks Equity Research
Pulse Biosciences (PLSE) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
New Strong Buy Stocks for April 24th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Pulse Biosciences Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Pulse Biosciences has been struggling lately, but the selling pressure may be coming to an end soon.